<DOC>
	<DOCNO>NCT00774527</DOCNO>
	<brief_summary>Randomized comparison cyclophosphamide versus reduced-dose cyclophosphamide plus fludarabine addition anti-thymocyte globulin conditioning therapy allogeneic hematopoietic cell transplantation bone marrow failure syndrome .</brief_summary>
	<brief_title>Comparison Cy-Atg Vs Cy-Flu-Atg Conditioning Therapy Allo-HCT</brief_title>
	<detailed_description>This prospective , randomize , non-blind study . Conditioning therapy start day -5 patient randomized receive Cy+ATG . Hydration 0.45 % NaCl 6 liters/24 hour start day -5 . Cy 50 mg/kg D5W 200 ml i.v . 1-2 hour day -5 -2 pump central venous catheter . Mesna 12 mg/kg iv push immediately Cy 3 , 6 , 9 , 12 hour Cy . Thymoglobuline 3 mg/kg N/S 500-800 mL ( le 0.5 mg/mL ) lymphoglobuline 15 mg/kg N/S 500-800 mL ( le 2 mg/mL ) iv daily 8 day -4 -2 . Premedication ATG ( ALG ) include methylprednisolone 2 mg/kg iv infusion , Tylenol 600 mg po , Avil 45.5 mg iv push . The dos cyclophosphamide ATG ( ALG ) calculate use actual body weight . Conditioning therapy start day -6 patient randomized receive Cy+fludarabine ( FludaraÂ® , Berlex Laboratories , Richmond , CA ) +ATG . Fludarabine 30 mg/m2 infuse intravenously 30 minute D5W 100 ml 5 consecutive day ( day -6 -2 ) . Thymoglobuline 3 mg/kg N/S 500-800 mL ( le 0.5 mg/mL ) lymphoglobuline 15 mg/kg N/S 500-800 mL ( le 2 mg/mL ) iv daily 8 day -4 -2 . Premedication ATG ( ALG ) include methylprednisolone 2 mg/kg iv infusion , Tylenol 600 mg po , Avil 45.5 mg iv push . Hydration 0.45 % NaCl 6 liters/24 hour start day -3 . Cy 50 mg/kg D5W 200 ml i.v . 1-2 hour day -3 -2 pump central venous catheter . Mesna 12 mg/kg iv push immediately Cy 3 , 6 , 9 , 12 hour Cy . The dos cyclophosphamide ATG ( ALG ) calculate use actual body weight .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Pancytopenia</mesh_term>
	<mesh_term>Hemoglobinuria , Paroxysmal</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Fludarabine phosphate</mesh_term>
	<mesh_term>Antilymphocyte Serum</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<criteria>Patients bone marrow failure syndrome . Written informed consent must obtain patient donor . Patients HLAidentical onelocus mismatch sibling , family unrelated donor 60 year less . Patients 15 year age old , young 60 year . The performance status patient 70 Karnofsky performance scale ( see Appendix I ) . Patients major illness organ failure . Patients must adequate hepatic function ( bilirubin le 2 mg/dl , AST ALT less three time upper normal limit ) . Patients must adequate renal function ( creatinine le 2.0 mg/dl ) . Patients must adequate cardiac function ( ejection fraction &gt; 45 % MUGA scan ) . Patients must psychiatric disorder mental deficiency severe make compliance treatment unlikely , make informed consent impossible . Patients must pregnancy . Patients major illness organ failure</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>